SCHEMBL27643511

SCHEMBL27643511

O=c1oc2cc(F)ccc2c(CCO)c1-c1ccc(O)cc1O.O=c1oc2cc(O)ccc2c(CCO)c1-c1ccc(O)cc1O

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 11/20 0.58
▸ ESR2 Q92731 4/20 0.52
▸ NQO1 P15559 2/20 0.48
▸ KDM4E B2RXH2 1/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ GLA P06280 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ MIF P14174 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ HSD17B3 P37058 2/20 0.43
▸ PKLR P30613 1/20 0.43
▸ NOX4 Q9NPH5 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5123944 0.99 ESR1 (0.56) ESR1ESR2NQO1KDM4EMEN1
SCHEMBL5111890 0.93 ESR1 (0.58) ESR1ESR2NQO1KDM4EMEN1
SCHEMBL5111169 0.85 TP53 (0.53) ESR1ESR2NQO1KDM4EMEN1
SCHEMBL5116838 0.83 MEN1 (0.51) ESR1ESR2NQO1KDM4EMEN1
SCHEMBL1357283 0.83 ESR1 (0.48) ESR1ESR2NQO1KDM4EALDH1A1
SCHEMBL12137353 0.82 ESR1 (0.47) ESR1ESR2NQO1KDM4EALDH1A1
SCHEMBL1357425 0.80 ESR1 (0.46) ESR1ESR2HSD17B3
SCHEMBL5110923 0.79 ESR1 (0.67) ESR1ESR2NQO1HSD17B3
SCHEMBL14277816 0.79 ESR1 (0.60) ESR1ESR2NQO1KDM4EMEN1
SCHEMBL5113467 0.78 NQO1 (0.49) ESR1ESR2NQO1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101450950-A Tetracyclic heterocompounds as estrogen receptor modulators ORTHO MCNEIL PHARM INC (US) 2009-06-10 — — CN disclosed
CN-1745085-A Novel tetracyclic heteroatom containing derivatives as selective estrogen receptor modulators ORTHO MCNEIL PHARM INC (US) 2006-03-08 — — CN disclosed
Send feedback